This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure (DIURESIS-CHF)

This study is currently recruiting participants.
See Contacts and Locations
Verified October 2016 by Wilfried Mullens, MD PhD, Ziekenhuis Oost-Limburg
Sponsor:
Collaborators:
Ziekenhuis Oost-Limburg
University Hospital Leuven, Leuven, Belgium
Information provided by (Responsible Party):
Wilfried Mullens, MD PhD, Ziekenhuis Oost-Limburg
ClinicalTrials.gov Identifier:
NCT01973335
First received: October 25, 2013
Last updated: October 27, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2018
  Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)